Phathom Pharmaceuticals, Inc. (PHAT) vs Replimune Group, Inc. (REPL)
Detailed comparison between Phathom Pharmaceuticals, Inc., Replimune Group, Inc..Total Return (%)
Phathom Pharmaceuticals, Inc. (PHAT)Replimune Group, Inc. (REPL)
Which stock do you think will perform better?
Phathom Pharmaceuticals, Inc.
PHAT
Replimune Group, Inc.
REPL
| Metric | Phathom Pharmaceuticals, Inc. (PHAT) | Replimune Group, Inc. (REPL) |
|---|---|---|
| Current Price | $6.96 | $10.14 |
| Change | 0.00 (0.00%) | -0.22 (-2.12%) |
| Market Cap | $0.48B | $0.78B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -1.74 | -3.77 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $19.71 | $17.00 |
| 52-Week Low | $6.07 | $4.92 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-5.74 | $-3.04 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| PHAT | -6.58% | 0.00% | -11.34% | -81.32% | -71.71% | -71.71% |
| REPL | -18.82% | 0.00% | 29.17% | -44.38% | -33.11% | -33.11% |